'Jimmie's Law' provides stricter regulations on pharmaceutical compounding in Kentucky - WLKY
Kentucky's 'Jimmie's Law' imposes stricter regulations on pharmaceutical compounding, including new requirements for sterile compounding, patient-specific labeling, and reporting to the state board of pharmacy.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Compounding pharmacies in Kentucky, including independent, retail chain, and long-term-care pharmacies that perform compounding. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective immediately upon passage; full compliance expected within 90 days.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New requirements for sterile compounding (USP 797 compliance), mandatory patient-specific labeling, and increased reporting obligations to the Kentucky Board of Pharmacy.
Who it affects
Compounding pharmacies in Kentucky, including independent, retail chain, and long-term-care pharmacies that perform compounding.
What you must do
Review and update compounding procedures to meet new sterile compounding standards, implement patient-specific labeling, and establish reporting protocols.
Deadline
Effective immediately upon passage; full compliance expected within 90 days.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Pharmacy technicians must register with Florida's Board of Pharmacy by Jan. 1, 2010 - Drug Topics
- Judge Trims DEA's Suspension Of Fla. Pharmacy's Permits - Law360
- New Wisconsin Law Regulates PBM and Other Stakeholders Involved in Drug Pricing - Quarles
- Pharmacists in WV can now give COVID-19 vaccines without prescriptions - Charleston Gazette-Mail
- What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - Reed Smith LLP